SEC Form 4 · accession 0001209191-16-151190
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J. Kafka
Officer — President & COO
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 16, 2016 | M | 1,000 | $4.16 | A | 102,550 | D | |
| Common StockF1 | Nov 16, 2016 | S | 1,000 | $23.00 | D | 101,550 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock option (right to buy)F2 | $4.16 | Nov 16, 2016 | M | 1,000 | D | — | Mar 7, 2023 | Common Stock | 1,000 | 4,168 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2016.
- F2This is a non-qualified portion of an option granted on March 7, 2013 that vested 25% on January 2, 2014 and then vests in equal quarterly installments until fully vested on January 2, 2017.